|
Volumn 29, Issue 1-2, 1997, Pages 800-801
|
Role of PCR in the diagnosis and management of CMV in solid organ recipients: What is the predictive value for development of disease and should PCR be used to guide antiviral therapy?
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
OKT 3;
THYMOCYTE ANTIBODY;
CONFERENCE PAPER;
CYTOMEGALOVIRUS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
GRAFT REJECTION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
ORGAN TRANSPLANTATION;
POLYMERASE CHAIN REACTION;
PREDICTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SERODIAGNOSIS;
ANTILYMPHOCYTE SERUM;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
FALSE POSITIVE REACTIONS;
GANCICLOVIR;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
MUROMONAB-CD3;
PANCREAS TRANSPLANTATION;
POLYMERASE CHAIN REACTION;
POSTOPERATIVE COMPLICATIONS;
PREDICTIVE VALUE OF TESTS;
RETROSPECTIVE STUDIES;
SEROLOGIC TESTS;
|
EID: 0030911997
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(96)00108-X Document Type: Conference Paper |
Times cited : (8)
|
References (10)
|